Novel approaches to the study of postmortem brain in psychiatric illness: Old limitations and new challenges

Biological Psychiatry

Volumn 69, Issue 2, 2011, Pages 127-133

  McCullumsmith, Robert E ^a   Meador Woodruff, James H ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Laser capture microdissection; mass spectrometry; postmortem; RNA integrity; schizophrenia; subcellular fractionization

Indexed keywords

MESSENGER RNA;

AUTOPSY; CAUSE OF DEATH; CELL FRACTIONATION; DNA MICROARRAY; DRUG EXPOSURE; EPIGENETICS; HUMAN; LASER CAPTURE MICRODISSECTION; MENTAL DISEASE; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE; SCIENTIST;

AUTOPSY; BRAIN; BRAIN CHEMISTRY; BRAIN DISEASES; HUMANS; MENTAL DISORDERS; MICRODISSECTION; NERVE TISSUE PROTEINS; NEUROPSYCHIATRY; POSTMORTEM CHANGES; RNA, MESSENGER; SPECIMEN HANDLING;

EID: 78650432382     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.09.035     Document Type: Review

References (100)

1. A.D. Stan, S. Ghose, X.M. Gao, R.C. Roberts, K. Lewis-Amezcua, and K.J. Hatanpaa Human postmortem tissue: What quality markers matter? Brain Res 1123 2006 1 11
2. J.H. Meador-Woodruff, and S.J. Watson Postmortem studies in schizophrenic brain J Psychiatr Res 31 1997 157 158
3. D.A. Lewis The human brain revisited: Opportunities and challenges in postmortem studies of psychiatric disorders Neuropsychopharmacology 26 2002 143 154
4. M.R. Hynd, J.M. Lewohl, H.L. Scott, and P.R. Dodd Biochemical and molecular studies using human autopsy brain tissue J Neurochem 85 2003 543 562
5. B.K. Lipska, A. Deep-Soboslay, C.S. Weickert, T.M. Hyde, C.E. Martin, and M.M. Herman Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia Biol Psychiatry 60 2006 650 658
6. S. Bahn, S.J. Augood, M. Ryan, D.G. Standaert, M. Starkey, and P.C. Emson Gene expression profiling in the post-mortem human brainno cause for dismay J Chem Neuroanat 22 2001 79 94
7. M.J. Webster Tissue preparation and banking Prog Brain Res 158 2006 3 14
8. S. Dracheva, S.A. Marras, S.L. Elhakem, F.R. Kramer, K.L. Davis, and V. Haroutunian N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia Am J Psychiatry 158 2001 1400 1410
9. S. Le Corre, C.G. Harper, P. Lopez, P. Ward, and S. Catts Increased levels of expression of an NMDARI splice variant in the superior temporal gyrus in schizophrenia Neuroreport 11 2000 983 986
10. B.P. Sokolov Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: Evidence on reversible up-regulation by typical neuroleptics J Neurochem 71 1998 2454 2464
11. S. Akbarian, N.J. Sucher, D. Bradley, A. Tafazzoli, D. Trinh, and W.P. Hetrick Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics J Neurosci 16 1996 19 30
12. T.D. Rea Agonal respirations during cardiac arrest Curr Opin Crit Care 11 2005 188 191
13. H. Tomita, M.P. Vawter, D.M. Walsh, S.J. Evans, P.V. Choudary, and J. Li Effect of agonal and postmortem factors on gene expression profile: Quality control in microarray analyses of postmortem human brain Biol Psychiatry 55 2004 346 352
14. C.S. Weickert, D. Sheedy, D.A. Rothmond, I. Dedova, S. Fung, and T. Garrick Selection of reference gene expression in a schizophrenia brain cohort Aust N Z J Psychiatry 44 2010 59 70
15. P.J. Harrison, A.W. Procter, A.J. Barton, S.L. Lowe, A. Najlerahim, and P.H. Bertolucci Terminal coma affects messenger RNA detection in post mortem human temporal cortex Brain Res Mol Brain Res 9 1991 161 164
16. A.J. Barton, R.C. Pearson, A. Najlerahim, and P.J. Harrison Pre- and postmortem influences on brain RNA J Neurochem 61 1993 1 11
17. P.J. Harrison, P.R. Heath, S.L. Eastwood, P.W. Burnet, B. McDonald, and R.C. Pearson The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: Selective mRNA vulnerability and comparison with their encoded proteins Neurosci Lett 200 1995 151 154
18. M.P. Vawter, H. Tomita, F. Meng, B. Bolstad, J. Li, and S. Evans Mitochondrial-related gene expression changes are sensitive to agonal-pH state: Implications for brain disorders Mol Psychiatry 11 2006 663 679
19. A.E. Kingsbury, O.J. Foster, A.P. Nisbet, N. Cairns, L. Bray, and D.J. Eve Tissue pH as an indicator of mRNA preservation in human post-mortem brain Brain Res Mol Brain Res 28 1995 311 318
20. P.F. Durrenberger, S. Fernando, S.N. Kashefi, I. Ferrer, J.J. Hauw, and D. Seilhean Effects of ante mortem and postmortem variables on human brain mRNA quality: A BrainNet Europe study J Neuropathol Exp Neurol 69 2010 70 81
21. A. Schroeder, O. Mueller, S. Stocker, R. Salowsky, M. Leiber, and M. Gassmann The RIN: An RNA integrity number for assigning integrity values to RNA measurements BMC Mol Biol 7 2006 3
22. J.A. Hardy, P. Wester, B. Winblad, C. Gezelius, G. Bring, and A. Eriksson The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue J Neural Transm 61 1985 253 264
23. J.F. Ervin, E.L. Heinzen, K.D. Cronin, D. Goldstein, M.H. Szymanski, and J.R. Burke Postmortem delay has minimal effect on brain RNA integrity J Neuropathol Exp Neurol 66 2007 1093 1099
24. C.L. Miller, S. Diglisic, F. Leister, M. Webster, and R.H. Yolken Evaluating RNA status for RT-PCR in extracts of postmortem human brain tissue BioTechniques 36 2004 628 633
25. S. Imbeaud, E. Graudens, V. Boulanger, X. Barlet, P. Zaborski, and E. Eveno Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces Nucleic Acids Res 33 2005 e56
26. C.E. Jahn, A.O. Charkowski, and D.K. Willis Evaluation of isolation methods and RNA integrity for bacterial RNA quantitation J Microbiol Methods 75 2008 318 324
27. S. Fleige, and M.W. Pfaffl RNA integrity and the effect on the real-time qRT-PCR performance Mol Aspects Med 27 2006 126 139
28. S. Weis, I.C. Llenos, J.R. Dulay, M. Elashoff, F. Martinez-Murillo, and C.L. Miller Quality control for microarray analysis of human brain samples: the impact of postmortem factors, RNA characteristics, and histopathology J Neurosci Methods 165 2007 198 209
29. A. Castensson, L. Emilsson, P. Preece, and E.E. Jazin High-resolution quantification of specific mRNA levels in human brain autopsies and biopsies Genome Res 10 2000 1219 1229
30. J.H. Gilmore, C.P. Lawler, A.M. Eaton, and R.B. Mailman Postmortem stability of dopamine D1 receptor mRNA and D1 receptors Brain Res Mol Brain Res 18 1993 290 296
31. S. Leonard, J. Logel, D. Luthman, M. Casanova, D. Kirch, and R. Freedman Biological stability of mRNA isolated from human postmortem brain collections Biol Psychiatry 33 1993 456 466
32. S. Pardue, A.L. Zimmerman, and M. Morrison-Bogorad Selective postmortem degradation of inducible heat shock protein 70 (hsp70) mRNAs in rat brain Cell Mol Neurobiol 14 1994 341 357
33. S.A. Trotter, L.B. Brill 2nd, and J.P. Bennett Jr Stability of gene expression in postmortem brain revealed by cDNA gene array analysis Brain Res 942 2002 120 123
34. A. Oni-Orisan, L.V. Kristiansen, V. Haroutunian, J.H. Meador-Woodruff, and R.E. McCullumsmith Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia Biol Psychiatry 63 2008 766 775
35. S.M. Eggan, T. Hashimoto, and D.A. Lewis Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia Arch Gen Psychiatry 65 2008 772 784
36. Z. Freyberg, S.J. Ferrando, and J.A. Javitch Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action Am J Psychiatry 167 2010 388 396
37. V. Haroutunian, P. Katsel, S. Dracheva, and K.L. Davis The human homolog of the QKI gene affected in the severe dysmyelination "quaking" mouse phenotype: Downregulated in multiple brain regions in schizophrenia Am J Psychiatry 163 2006 1834 1837
38. A.J. Law, C.S. Weickert, T.M. Hyde, J.E. Kleinman, and P.J. Harrison Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: Molecular evidence for a pathology of dendritic spines Am J Psychiatry 161 2004 1848 1855
39. B. Basil, M. Mathews, B. Adetunji, and K. Budur The CATIE study Am J Psychiatry 163 2006 555 author reply: 555556
40. K. Toyooka, S. Iritani, T. Makifuchi, O. Shirakawa, N. Kitamura, and K. Maeda Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia J Neurochem 83 2002 797 806
41. A. Uezato, J.H. Meador-Woodruff, and R.E. McCullumsmith Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia Bipolar Disord 11 2009 711 725
42. C.A. Tamminga, J.M. Dale, L. Goodman, H. Kaneda, and N. Kaneda Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: A study in three rat strains Psychopharmacology 102 1990 474 478
43. C.A. Tamminga, G.K. Thaker, M. Moran, T. Kakigi, and X.M. Gao Clozapine in tardive dyskinesia: Observations from human and animal model studies J Clin Psychiatry 55 suppl B 1994 102 106
44. M. Akil, C.L. Edgar, J.N. Pierri, S. Casali, and D.A. Lewis Decreased density of tyrosine hydroxylase-immunoreactive axons in the entorhinal cortex of schizophrenic subjects Biol Psychiatry 47 2000 361 370
45. G.T. Konopaske, K.A. Dorph-Petersen, R.A. Sweet, J.N. Pierri, W. Zhang, and A.R. Sampson Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys Biol Psychiatry 63 2008 759 765
46. L.A. Glantz, and D.A. Lewis Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia Regional and diagnostic specificity Arch Gen Psychiatry 54 1997 660 669
47. J.N. Pierri, C.L. Volk, S. Auh, A. Sampson, and D.A. Lewis Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia Arch Gen Psychiatry 58 2001 466 473
48. C.S. Carter, and D.S. Pine Polishing the windows of the mind Am J Psychiatry 163 2006 761 763
49. G. Hasler, W.C. Drevets, H.K. Manji, and D.S. Charney Discovering endophenotypes for major depression Neuropsychopharmacology 29 2004 1765 1781
50. E.A. Hazlett, M.J. Romero, M.M. Haznedar, A.S. New, K.E. Goldstein, and R.E. Newmark Deficient attentional modulation of startle eyeblink is associated with symptom severity in the schizophrenia spectrum Schizophr Res 93 2007 288 295
51. K.A. Dorph-Petersen, D. Caric, R. Saghafi, W. Zhang, A.R. Sampson, and D.A. Lewis Volume and neuron number of the lateral geniculate nucleus in schizophrenia and mood disorders Acta Neuropathol 117 2009 369 384
52. R.E. McCullumsmith, and J.H. Meador-Woodruff Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder Neuropsychopharmacology 26 2002 368 375
53. A. Yoshii, T. Koji, N. Ohsawa, and P.K. Nakane In situ localization of ribosomal RNAs is a reliable reference for hybridizable RNA in tissue sections J Histochem Cytochem 43 1995 321 327
54. M. Atz, D. Walsh, P. Cartagena, J. Li, S. Evans, and P. Choudary Methodological considerations for gene expression profiling of human brain J Neurosci Methods 163 2007 295 309
55. M.S. Sodhi, D.C. Airey, W. Lambert, P.W. Burnet, P.J. Harrison, and E. Sanders-Bush A rapid new assay to detect RNA editing reveals antipsychotic-induced changes in serotonin-2C transcripts Mol Pharmacol 68 2005 711 719
56. B. Dean, S. Boer, A. Gibbons, T. Money, and E. Scarr Recent advances in postmortem pathology and neurochemistry in schizophrenia Curr Opin Psychiatry 22 2009 154 160
57. K. Li, Y. Blum, A. Verma, Z. Liu, K. Pramanik, and N.R. Leigh A noncoding antisense RNA in Tie-1 locus regulates Tie-1 function in vivo Blood 115 2010 133 139
58. B.M. Ross, J.T. Knowler, and J. McCulloch On the stability of messenger RNA and ribosomal RNA in the brains of control human subjects and patients with Alzheimer's disease J Neurochem 58 1992 1810 1819
59. V.S. Catts, S.V. Catts, H.R. Fernandez, J.M. Taylor, E.J. Coulson, and L.H. Lutze-Mann A microarray study of post-mortem mRNA degradation in mouse brain tissue Brain Res Mol Brain Res 138 2005 164 177
60. T.J. Cummings, J.C. Strum, L.W. Yoon, M.H. Szymanski, and C.M. Hulette Recovery and expression of messenger RNA from postmortem human brain tissue Mod Pathol 14 2001 1157 1161
61. M. Mayne, P.N. Shepel, and J.D. Geiger Recovery of high-integrity mRNA from brains of rats killed by high-energy focused microwave irradiation Brain Res Brain Res Protoc 4 1999 295 302
62. S.A. Johnson, D.G. Morgan, and C.E. Finch Extensive postmortem stability of RNA from rat and human brain J Neurosci Res 16 1986 267 280
63. T. Popova, D. Mennerich, A. Weith, and K. Quast Effect of RNA quality on transcript intensity levels in microarray analysis of human post-mortem brain tissues BMC Genomics 9 2008 91
64. K.L. Davis, D.G. Stewart, J.I. Friedman, M. Buchsbaum, P.D. Harvey, and P.R. Hof White matter changes in schizophrenia: Evidence for myelin-related dysfunction Arch Gen Psychiatry 60 2003 443 456
65. Y. Hakak, J.R. Walker, C. Li, W.H. Wong, K.L. Davis, and J.D. Buxbaum Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia Proc Natl Acad Sci U S A 98 2001 4746 4751
66. D. Tkachev, M.L. Mimmack, M.M. Ryan, M. Wayland, T. Freeman, and P.B. Jones Oligodendrocyte dysfunction in schizophrenia and bipolar disorder Lancet 362 2003 798 805
67. L.V. Kristiansen, M. Beneyto, V. Haroutunian, and J.H. Meador-Woodruff Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia Mol Psychiatry 11 2006 737 747 705
68. D. Bauer, D. Gupta, V. Harotunian, J.H. Meador-Woodruff, and R.E. McCullumsmith Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia Schizophr Res 104 2008 108 120
69. C.Y. Pietersen, M.P. Lim, and T.U. Woo Obtaining high quality RNA from single cell populations in human postmortem brain tissue [August 6] J Vis Exp 2009
70. S.S. Wang, W. Kamphuis, I. Huitinga, J.N. Zhou, and D.F. Swaab Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: The presence of multiple receptor imbalances Mol Psychiatry 13 2008 786 799 741
71. I.A. Kerman, B.J. Buck, S.J. Evans, H. Akil, and S.J. Watson Combining laser capture microdissection with quantitative real-time PCR: Effects of tissue manipulation on RNA quality and gene expression J Neurosci Methods 153 2006 71 85
72. W. Byne, S. Dracheva, B. Chin, J.M. Schmeidler, K.L. Davis, and V. Haroutunian Schizophrenia and sex associated differences in the expression of neuronal and oligodendrocyte-specific genes in individual thalamic nuclei Schizophr Res 98 2008 118 128
73. W.B. Ruzicka, A. Zhubi, M. Veldic, D.R. Grayson, E. Costa, and A. Guidotti Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection Mol Psychiatry 12 2007 385 397
74. U.V. Berger, T.M. DeSilva, W. Chen, and P.A. Rosenberg Cellular and subcellular mRNA localization of glutamate transporter isoforms GLT1a and GLT1b in rat brain by in situ hybridization J Comp Neurol 492 2005 78 89
75. F. Loup, O. Weinmann, Y. Yonekawa, A. Aguzzi, H.G. Wieser, and J.M. Fritschy A highly sensitive immunofluorescence procedure for analyzing the subcellular distribution of GABAA receptor subunits in the human brain J Histochem Cytochem 46 1998 1129 1139
76. A. Matevossian, and S. Akbarian A chromatin assay for human brain tissue [March 21] J Vis Exp 2008
77. S. Akbarian, and H.S. Huang Epigenetic regulation in human brain-focus on histone lysine methylation Biol Psychiatry 65 2009 198 203
78. S. Akbarian The molecular pathology of schizophrenia-focus on histone and DNA modifications Brain Res Bull 83 2009 103 107
79. C.M. Connor, and S. Akbarian DNA methylation changes in schizophrenia and bipolar disorder Epigenetics 3 2008 55 58
80. D.E. Bauer, V. Haroutunian, R.E. McCullumsmith, and J.H. Meador-Woodruff Expression of four housekeeping proteins in elderly patients with schizophrenia J Neural Transm 116 2009 487 491
81. S.L. Eastwood, and P.J. Harrison Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography Neuroscience 69 1995 339 343
82. D.A. Cruz, S.M. Eggan, E.C. Azmitia, and D.A. Lewis Serotonin1A receptors at the axon initial segment of prefrontal pyramidal neurons in schizophrenia Am J Psychiatry 161 2004 739 742
83. R.A. Sweet, R.A. Henteleff, W. Zhang, A.R. Sampson, and D.A. Lewis Reduced dendritic spine density in auditory cortex of subjects with schizophrenia Neuropsychopharmacology 34 2009 374 389
84. S.L. Eastwood, M. Walker, T.M. Hyde, J.E. Kleinman, and P.J. Harrison The DISC1 Ser704Cys substitution affects centrosomal localization of its binding partner PCM1 in glia in human brain Hum Mol Genet 19 2010 2487 2496
85. A.T. Behan, C. Byrne, M.J. Dunn, G. Cagney, and D.R. Cotter Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression Mol Psychiatry 14 2009 601 613
86. K. Pennington, C.L. Beasley, P. Dicker, A. Fagan, J. English, and C.M. Pariante Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder Mol Psychiatry 13 2008 1102 1117
87. C.L. Beasley, K. Pennington, A. Behan, R. Wait, M.J. Dunn, and D. Cotter Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes Proteomics 6 2006 3414 3425
88. C.G. Hahn, H.Y. Wang, D.S. Cho, K. Talbot, R.E. Gur, and W.H. Berrettini Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia Nat Med 12 2006 824 828
89. C.G. Hahn, A. Banerjee, M.L. Macdonald, D.S. Cho, J. Kamins, and Z. Nie The post-synaptic density of human postmortem brain tissues: An experimental study paradigm for neuropsychiatric illnesses PLoS ONE 4 2009 e5251
90. T. Frohlich, and G.J. Arnold Proteome research based on modern liquid chromatographytandem mass spectrometry: Separation, identification and quantification J Neural Transm 113 2006 973 994
91. B.C. Yoo, R. Seidl, N. Cairns, and G. Lubec Heat-shock protein 70 levels in brain of patients with Down syndrome and Alzheimer's disease J Neural Transm Suppl 57 1999 315 322
92. C.M. Yates, J. Butterworth, M.C. Tennant, and A. Gordon Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias J Neurochem 55 1990 1624 1630
93. K.F. Faull, S.S. Bowersox, L. Zeller-DeAmicis, J.F. Maddaluno, R.D. Ciaranello, and W.C. Dement Influence of freezer storage time on cerebral biogenic amine and metabolite concentrations and receptor ligand binding characteristics Brain Res 450 1988 225 230
94. K.A. Newell, C. Deng, and X.F. Huang Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia Exp Brain Res 172 2006 556 560
95. S. Ghose, C.S. Weickert, S.M. Colvin, J.T. Coyle, M.M. Herman, and T.M. Hyde Glutamate carboxypeptidase II gene expression in the human frontal and temporal lobe in schizophrenia Neuropsychopharmacology 29 2004 117 125
96. G. Tsai, L.A. Passani, B.S. Slusher, R. Carter, L. Baer, and J.E. Kleinman Abnormal excitatory neurotransmitter metabolism in schizophrenic brains Arch Gen Psychiatry 52 1995 829 836
97. V.E. Barakauskas, C.L. Beasley, A.M. Barr, A.R. Ypsilanti, H.Y. Li, and A.E. Thornton A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia Neuropsychopharmacology 35 2010 1226 1238
98. L.V. Kristiansen, S.A. Patel, V. Haroutunian, and J.H. Meador-Woodruff Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia Synapse 64 2010 495 502
99. J.C. Hammond, R.E. McCullumsmith, A.J. Funk, V. Haroutunian, and J.H. Meador-Woodruff Evidence for abnormal forward trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia Neuropsychopharmacology 35 2010 2110 2119
100. P. Bubber, J. Tang, V. Haroutunian, H. Xu, K.L. Davis, and J.P. Blass Mitochondrial enzymes in schizophrenia J Mol Neurosci 24 2004 315 321